A post-hoc analysis of the phase 3b JUMP trial found that ruxolitinib plus anemia supportive care maintained efficacy and reduced transfusion needs in patients with myelofibrosis.

A post-hoc analysis of the phase 3b JUMP trial assessed outcomes in patients with myelofibrosis and baseline anemia who were treated with ruxolitinib alongside anemia-supportive therapies, according ...

In fact, treatment might need to be started even if the diagnosis of APL is suspected but hasn't been confirmed yet by lab tests. APL treatment differs from the treatment of most other types of AML.

Over a hundred sickle cell warriors and their families turned out in support for World Sickle Cell Day at West Oakland’s ...

During a live event, Thomas LeBlanc, MD, MA, discussed the outcomes of the COMMANDS trial of luspatercept in myelodysplastic ...

Learn more about myocardial ischemia, which is often caused by severe anemia and results in a disruption of blood flow to the ...

Anemia is a common condition and has many causes, one of which is hemolytic disease of the fetus and newborn (HDFN), a ...

New findings reveal that combining erythropoiesis-stimulating agents with ruxolitinib maintains efficacy in treating ...

The best way to treat UC-related anemia is to manage ulcerative colitis. This can help control the bleeding in the large intestine to limit blood loss (and the resulting iron deficiency anemia) ...

But, that doesn’t mean the treatment didn’t work. “I’ve had patients say, ‘This is totally transformative for me. I can finally get out of bed in the morning,’” said Malina.

This is the first randomised controlled trial of CAR T-cell therapy in solid tumours globally. Satri-cel treatment resulted in a significant improvement in progression-free survival, with a manageable ...

Shari Redstone, the media mogul who has been trying to sell Paramount in a politically fraught transaction, is undergoing treatment for cancer. Redstone “was diagnosed with thyroid cancer ...